Equate Beauty
Salicylic Acid
Walmart Inc.
Human Otc Drug
NDC 79903-138Equate Beauty also known as Salicylic Acid is a human otc drug labeled by 'Walmart Inc.'. National Drug Code (NDC) number for Equate Beauty is 79903-138. This drug is available in dosage form of Soap. The names of the active, medicinal ingredients in Equate Beauty drug includes Salicylic Acid - 2000 mg/100mL . The currest status of Equate Beauty drug is Active.
Drug Information:
| Drug NDC: | 79903-138 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Equate Beauty |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Salicylic Acid |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Walmart Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Soap |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | SALICYLIC ACID - 2000 mg/100mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 19 Jul, 2022 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 14 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | M006 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | WALMART INC.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 562600
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | O414PZ4LPZ
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 79903-138-06 | 177 mL in 1 BOTTLE, PLASTIC (79903-138-06) | 19 Jul, 2022 | N/A | No |
| 79903-138-09 | 269 mL in 1 BOTTLE, PLASTIC (79903-138-09) | 19 Jul, 2022 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Acne treatment
Product Elements:
Equate beauty salicylic acid fd&c red no. 40 fragrance clean orc0600327 water matricaria chamomilla flowering top basic yellow 5 edetate disodium cocamidopropyl pg-dimonium chloride phosphate aloe vera leaf sodium hydroxide salicylic acid salicylic acid peg-80 sorbitan laurate c12-15 alkyl lactate benzalkonium chloride citric acid monohydrate sodium c14-16 olefin sulfonate cocamidopropyl betaine sodium chloride
Indications and Usage:
Indication and usage to be used to treat pimples (acne)..
Warnings:
For external use only: flammable keep away from source of heat or fire ask doctor or pharmacist before use if you are ask doctor or pharmacist before use if you are using other topical acne medications at the same time or immediately following use of this product. this may increase dryness or irritation of the skin. if this occurs, only one medication should be used unless otherwise directed by a doctor. when using this product when using this product avoid contact with eyes. if contact occurs, rinse eyes thoroughly with water for 15 minutes. stop use and ask a doctor stop use and ask a doctor if irritation, dryness or redness develops and lasts. ask doctor before use if pregnant/breastfeeding. keep out of reach of children. in case of accidental ingestion, get medical help or contact a poison control center immediately.
When Using:
When using this product when using this product avoid contact with eyes. if contact occurs, rinse eyes thoroughly with water for 15 minutes.
Dosage and Administration:
Directions new users: apply to small area before use to test for sensitivity. if no discomfort occurs, apply to affected area and rinse off. start with one application and gradually increase to 2-3 times daily if needed or as directed by physician.
Stop Use:
Stop use and ask a doctor stop use and ask a doctor if irritation, dryness or redness develops and lasts. ask doctor before use if pregnant/breastfeeding.
Package Label Principal Display Panel:
Pdp-01 pdp-01
Pdp-02 pdp-02